America First Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

America First Investment Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$8.88K	–	48
2024 Q2	$8.88K	Hold	4,000	–	–	﹤0.01%	73
2024 Q1	$21.4K	Hold	4,000	–	–	0.01%	67
2023 Q4	$5.92K	Hold	4,000	–	–	﹤0.01%	93
2023 Q3	$5.56K	Hold	4,000	–	–	﹤0.01%	93
2023 Q2	$5.88K	Hold	4,000	–	–	﹤0.01%	95
2023 Q1	$6.6K	Hold	4,000	–	–	﹤0.01%	96
2022 Q4	$6K	Hold	4,000	–	–	﹤0.01%	85
2022 Q3	$6K	Hold	4,000	–	–	﹤0.01%	78
2022 Q2	$9K	Hold	4,000	–	–	﹤0.01%	67
2022 Q1	$10K	Hold	4,000	–	–	﹤0.01%	70
2021 Q4	$24K	Hold	4,000	–	–	0.01%	59
2021 Q3	$27K	Hold	4,000	–	–	0.01%	61
2021 Q2	$27K	Hold	4,000	–	–	0.01%	61
2021 Q1	$37K	Buy	+4,000	New	+$48.6K	0.01%	59

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

America First Investment Advisors's CRDF Position: Q3 2024 in Review

America First Investment Advisors sold out of Cardiff Oncology (CRDF) in Q3 2024, closing a stake of 4,000 shares — an estimated $8.88K sold.

America First Investment Advisors first reported a position in CRDF in Q1 2021 and held it in 14 quarters. The position peaked at $37K in Q1 2021. 83 funds tracked by Wall St. Rank hold CRDF as of Q3 2024.

America First Investment Advisors reported no remaining Cardiff Oncology position as of Q3 2024 after selling out during the quarter.
America First Investment Advisors sold 4,000 Cardiff Oncology shares in Q3 2024, an estimated $8.88K.
America First Investment Advisors first reported a position in Cardiff Oncology in Q1 2021 and held it in 14 quarters.
America First Investment Advisors's Cardiff Oncology position peaked at $37K in Q1 2021.
83 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2024.

Based on America First Investment Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.